ArticleEuropean radiology2021
A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis.
Article in European radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Integrating Artificial Intelligence into Prostate MR Imaging: Technical Foundations, Clinical Applications, and Workflow Implications.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2026Review
- Diagnostic value of prostate magnetic resonance imaging in men with prostate-specific antigen levels ≥ 15 ng/mL for biopsy decision-making.Insights into imaging · 2026Article
- Prostate MRI cancer detection rate by deep learning-assisted image quality categorization: gas-induced susceptibility artifacts in diffusion-weighted imaging.Insights into imaging · 2025Article
- A Narrative Review of Artificial Intelligence in MRI-Guided Prostate Cancer Diagnosis: Addressing Key Challenges.Diagnostics (Basel, Switzerland) · 2025Review
- PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI.European radiology · 2024Article
- Enhancing prostate MRI expertise: educational strategies for radiologists.Abdominal radiology (New York) · 2024Review
- Impact of Prostate Urethral Lift Device on Prostate Magnetic Resonance Image Quality.The Journal of urology · 2023Article
- Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship.European radiology · 2023Article
- Better Image Quality for Diffusion-weighted MRI of the Prostate Using Deep Learning.Radiology · 2022Article
- Deep learning-based artificial intelligence applications in prostate MRI: brief summary.The British journal of radiology · 2022Review
- PI-QUAL v.1: the first step towards good-quality prostate MRI.European radiology · 2022Article
- Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.European radiology · 2022Article
- Current Opinion Regarding Multidisciplinary Cancer Clinic Utilization for the Management of Prostate Cancer.Journal of clinical imaging science · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
key points• Identify, assure, and measure major sources of variability affecting the MRI-directed biopsy pathway for prostate cancer diagnosis.• Develop strategies to control and minimize variations that impair pathway effectiveness including the performance of main players and team working.• Assure end-to-end quality of the diagnostic chain with robust multidisciplinary team working.
Indexed as
Identifiers
33241520What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.